Autobio Diagnostics Co Ltd (603658) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Based on the latest financial reports, Autobio Diagnostics Co Ltd (603658) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥435.24 Million ≈ $63.69 Million USD) by net assets (CN¥8.85 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 603658 company net worth for the company's overall valuation and market capitalisation.

Autobio Diagnostics Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Autobio Diagnostics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Autobio Diagnostics Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Autobio Diagnostics Co Ltd ranked by their cash flow conversion efficiency. Explore 603658 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Vapores SN:VAPORES	-0.073x
California Water Service Group NYSE:CWT	0.035x
Immunome Inc NASDAQ:IMNM	-0.117x
Himadri Speciality Chemical Limited NSE:HSCL	-0.020x
Foxconn Technology Co Ltd TW:2354	0.045x
Solusi Tunas Pratama Tbk JK:SUPR	0.174x
Manappuram Finance Limited NSE:MANAPPURAM	-0.196x
Allied Gold Corporation TO:AAUC	0.432x

Annual Cash Flow Conversion Efficiency for Autobio Diagnostics Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Autobio Diagnostics Co Ltd from 2011 to 2025. View Autobio Diagnostics Co Ltd (603658) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥9.02 Billion ≈ $1.32 Billion	CN¥1.34 Billion ≈ $196.33 Million	0.149x	-1.21%
2024-12-31	CN¥8.69 Billion ≈ $1.27 Billion	CN¥1.31 Billion ≈ $191.59 Million	0.151x	-11.19%
2023-12-31	CN¥8.67 Billion ≈ $1.27 Billion	CN¥1.47 Billion ≈ $215.09 Million	0.170x	-13.89%
2022-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.56 Billion ≈ $228.05 Million	0.197x	-0.21%
2021-12-31	CN¥7.40 Billion ≈ $1.08 Billion	CN¥1.46 Billion ≈ $213.82 Million	0.197x	+30.67%
2020-12-31	CN¥6.59 Billion ≈ $963.64 Million	CN¥994.71 Million ≈ $145.56 Million	0.151x	-52.79%
2019-12-31	CN¥2.63 Billion ≈ $385.52 Million	CN¥842.89 Million ≈ $123.34 Million	0.320x	-3.79%
2018-12-31	CN¥1.97 Billion ≈ $287.67 Million	CN¥653.73 Million ≈ $95.66 Million	0.333x	+16.62%
2017-12-31	CN¥1.69 Billion ≈ $247.22 Million	CN¥481.73 Million ≈ $70.49 Million	0.285x	+12.80%
2016-12-31	CN¥1.64 Billion ≈ $240.70 Million	CN¥415.82 Million ≈ $60.85 Million	0.253x	-41.15%
2015-12-31	CN¥718.55 Million ≈ $105.15 Million	CN¥308.63 Million ≈ $45.16 Million	0.430x	-16.26%
2014-12-31	CN¥500.94 Million ≈ $73.30 Million	CN¥256.93 Million ≈ $37.60 Million	0.513x	+69.15%
2013-12-31	CN¥340.42 Million ≈ $49.81 Million	CN¥103.22 Million ≈ $15.10 Million	0.303x	+2.28%
2012-12-31	CN¥233.84 Million ≈ $34.22 Million	CN¥69.32 Million ≈ $10.14 Million	0.296x	-8.02%
2011-12-31	CN¥156.96 Million ≈ $22.97 Million	CN¥50.59 Million ≈ $7.40 Million	0.322x	--

About Autobio Diagnostics Co Ltd

SHG:603658 China Medical Devices

Market Cap

$2.92 Billion

CN¥19.98 Billion CNY

Market Cap Rank

#5048 Global

#878 in China

Share Price

CN¥34.97

Change (1 day)

+7.53%

52-Week Range

CN¥28.72 - CN¥39.94

All Time High

CN¥131.73